Navigation Links
Statistical Bowl - How the '07 Patriots and the '72 Dolphins Match Up
Date:1/30/2008

PHOENIX, Jan. 30 /PRNewswire/ -- Sports pundits across the country have been comparing the so-far unbeaten 2007 New England Patriots to the perfect 1972 Dolphins all year. Now, a New York cardiologist is using the scientific statistics used in large-scale medical trials to determine which of the two teams is superior.

Using a format and approach typically reserved for the cardiovascular therapy studies he writes and reviews, Dr. Jonathan Sackner-Bernstein, a Food & Drug Administration advisor and the Chief Medical Officer at Clinilabs, a clinical research organization in New York, compares the 2007 New England Patriots and the 1972 Miami Dolphins.

Sackner-Bernstein was able to draw conclusions by analyzing the two teams' performance relative to their peers in categories that reflect their relative dominance: total offensive and defensive points and yards. Game-by-game performance for the 2007 Patriots and 1972 Dolphins was adjusted to be relative to all of the games played in each respective year, and then those results were compared directly. In statistical terms, the performance statistics were normalized to the median values. A second analysis further adjusted the two for the basis of comparison, by using the opponents' winning percentage to normalize the scores and yardage.

Sackner-Bernstein's data showed a statistical trend in favor of the Patriots as the better offensive team, scoring more than a touchdown more per game than the Dolphins. However, to counteract the offensive prowess of the Patriots, the '72 Dolphins defense gave up 50 percent fewer points than the '07 Patriots, giving the Dolphins a slight edge. The teams both enjoyed greater net yardage than their opponents by almost the same amount ('07 Patriots +123 yards vs. '72 Dolphins +124 yards).

Using the jargon of medical science, none of the differences noted were statistically significant. In the end, the statistical data show that, provided the Patriots win the S
'/>"/>

SOURCE MCS Public Relations
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
2. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. Gleaners Community Food Bank Board Members Match Donations December 19, 2007
5. Marianjoy Rehabilitation Hospital Therapeutic Golf Program Receives a $20,000 Matching Grant From the USGA
6. S3 Matching Technologies Aids in Reducing Risk to Texas Medicaid System
7. Many prostate cancer patients receive improper or mismatched therapies
8. Mismatched prostate cancer treatment more common than expected
9. BCP Veterinary Pharmacy Helps Cure Diabetic Cats with BCP PZI(R), the Closest Match to Feline Insulin Available
10. Neurotechnologija Releases Smartcard Face-Match Add-on for the Implementation of Biometric Face-on-Smartcard Verification Systems
11. Gene Tests Match Up Lung Tumors, Best Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... (PRWEB) February 26, 2015 In a nested-case ... of the world with a relatively low incidence of liver ... liver cancer, according to a new study published February ... Institute. , Previous studies have reported this association but ... high liver cancer incidence rate, such as Asia. Katherine A. ...
(Date:2/26/2015)... 2015 marks five years of being recognized ... , Orthodontics is a perfect blend of Dr. ... in biomedical engineering, his artistic talent, his extensive training ... allows Dr. Caggiano to create innovative approaches to solve ... Orthodontic Products’ Best of 2012, a national recognition, for ...
(Date:2/26/2015)... February 26, 2015 Beckman Coulter is ... extracellular vesicles and their cargo in cell-to-cell communication,” which ... their relevance for cell-to-cell communication. The webinar is free ... 2015 at 8:00am PT. , Every cell in the ... (EVs) , often called “exosomes” or “microvesicles.” These vesicles ...
(Date:2/26/2015)... “ KnowNote ” was featured on NewsWatch as part of ... applications on the iOS, Android, and Windows markets. Andrew Tropeano, ... app review and shared with viewers how this application teaches ... , Learning a musical instrument can be difficult. And ... take something they already know and use to learn music ...
(Date:2/26/2015)... Pittsburgh, PA (PRWEB) February 26, 2015 ... Chairman J. Robert Baum, Ph.D. is stepping down as ... succeeded by Joseph C. Guyaux, senior vice chairman of ... chief executive officer, PNC Mortgage. Additionally, Highmark Health President ... the chairman of the board of directors of Highmark ...
Breaking Medicine News(10 mins):Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 2Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3Health News:A Modern Way to Learn Music was Featured on NewsWatch Television on January 30, 2015 2Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 2Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 3Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 4
... 13 The second annual HealthSaver Caffeinated ... emerging health care discount service, found that the ... followed by Seattle, Chicago, New York and Los ... , The least caffeinated cities are Riverside/San ...
... COLUMBIA, Canada, Jan. 13 InNexus Biotechnology ... http://www.ixsbio.com ), a drug development company commercializing the next ... Linking (DXL(TM)) technology, announces the completion of a large ... lead candidate DXL625 (CD20). The Company also announced ...
... from CoSentry, a leading provider of data center ... of the nation,s premier healthcare providers, announced formation ... an enterprise class data center in Papillion, Neb.The ... requirements of Alegent Health,s hospital and clinical applications ...
... Misuse may cause respiratory distress, researchers say; company says ... -- The popular cold remedy Vicks VapoRub may cause ... toddlers, a new study says. , Doctors at Wake ... girl who had developed severe respiratory distress after the ...
... knee ligament reconstruction markets to grow at rates above ... to Millennium Research GroupWALTHAM, Mass., Jan. 13 ... US Markets for Orthopedic Soft Tissue ... for the use of composite materials in both shoulder ...
... Physical ActivitySACRAMENTO, Calif., Jan. 13 New research suggests ... a few clicks away with Dairy Council of California,s ... chronic diseases like type 2 diabetes, heart disease and ... (47.7 percent) engage in at least 30 minutes of ...
Cached Medicine News:Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 2Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 3Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 4Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 5Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 6Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 7Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 8Health News:InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedules Meeting With FDA 2Health News:CoSentry and Alegent Health Announce Collaboration for Construction of an Enterprise-Class Data Center 2Health News:CoSentry and Alegent Health Announce Collaboration for Construction of an Enterprise-Class Data Center 3Health News:CoSentry and Alegent Health Announce Collaboration for Construction of an Enterprise-Class Data Center 4Health News:Vicks VapoRub Linked to Infant Breathing Problems 2Health News:Vicks VapoRub Linked to Infant Breathing Problems 3Health News:Growing Preference for Composite Materials in Shoulder Fixation and Knee Ligament Reconstruction Markets 2Health News:MyFitness Planner Really Moves You 2
(Date:2/26/2015)... 2015  Lyric Pharmaceuticals Inc. today announced the initial ... million. The financing, co-led by RiverVest Venture Partners, Sante ... Venture Partners. Lyric is a clinical-stage ... , M.D., M.B.A., President & Chief Executive Officer and ... In 2014, Lyric closed a seed financing round of ...
(Date:2/26/2015)... 26, 2015 Columbia Laboratories, Inc. (Nasdaq: ... a specialty pharmaceutical company focused on the development ... a Phase II clinical trial for COL-1077, a ... pipelle-directed endometrial biopsy in the second quarter of ... submission feedback from the United States Food and ...
(Date:2/26/2015)... SALT LAKE CITY , Feb. 26, 2015 /PRNewswire/ ... it has launched a "best efforts" follow-on offering of ... unit consists of one share of Series E preferred ... Series E preferred stock will be convertible into four ... will be exercisable into one share of common stock ...
Breaking Medicine Technology:Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 2Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 3Great Basin Scientific, Inc. Announces Commencement of Public Offering 2Great Basin Scientific, Inc. Announces Commencement of Public Offering 3
... , , ... Designation , SILVER SPRING, Md., Dec. 23 As ... and accessible, the FDA has scheduled a series of workshops about ... the process. The FDA can grant a special status, known as ...
... , ATLANTA, Dec. 23 MiMedx Group, Inc. ... launched its first product, Paradis Vaso Shield(TM). In April ... for use as a cover for vessels following anterior vertebral ... hydrogel product protected by multiple patents and patent applications, as ...
Cached Medicine Technology:FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010 2MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device 2MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 11 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Medicine Products: